Geno<strong>to</strong>xicity of Nanomaterials: DNA damage <strong>and</strong>micronuclei induced by carbon nanotubes <strong>and</strong>graphite nanofibres in human bronchial epithelialcells in vitro. Toxicol Lett 186(3):166–173.Lison D, Muller J [2008]. Lung <strong>and</strong> systemic responses<strong>to</strong> carbon nanotubes (CNT) in mice. ToxicolSci 101(1):179–180.Liu A, Sun K, Yang J, Zhao D [2008]. Toxicologicaleffects of multi-wall carbon nanotubes in rats. JNanopart Res 10(8):1303–1307.Liu X, Hurt RH, Kane AB [2010]. Biodurability ofsingle-walled carbon nanotubes depends on surfacefunctionalization. <strong>Carbon</strong> N Y 48(7):1961–1969.Lux Research [2007]. The nanotech report. 5th ed.New York: Lux Research.Lyles RH, Kupper LL, Rappaport SM [1997]. A lognormaldistribution-based exposure assessment methodfor unbalanced data. Ann Occup Hyg 41(1):63–76.Mader BT, Flagan RC, Seinfeld JH [2001]. Samplingatmospheric carbonaceous aerosols using aparticle trap impac<strong>to</strong>r/denuder sampler. EnvironSci Technol 35(24):4857–4867.Mader BT, Schauer JJ, Seinfeld JH, Flagan RC, YeJZ, Yang H, Lim HJ, Turpin BJ, Deminter JT, HeidemannG, Bae MS, Quinn P, Bates T, Ea<strong>to</strong>ugh DJ,Huebert BJ, Bertram T, Howell S [2003]. Samplingmethods used for the collection of particle-phaseorganic <strong>and</strong> elemental carbon during ACE-Asia.Atmos Environ 37(11):1435–1449.Magrez A, Kasas S, Salicio V, Pasquier N, Seo JW,Celio M, Catsicas S, Schwaller B, Forró L [2006].Cellular <strong>to</strong>xicity of carbon-based nanomaterials.Nano Lett 6(6):1121–1125.Ma-Hock L, Treumann S, Strauss V, Brill S, LuiziF, Mertler M, Wiench K, Gamer AO, RavenzwaayB, L<strong>and</strong>siedel R [2009]. Inhalation <strong>to</strong>xicity ofmulti-wall carbon nanotubes in rats exposed for 3months. Toxicol Sci 112(2):468–481.Mangum JB, Turpin EA, Antao-Menezes A, CestaMF, Bermudez E, Bonner JC, [2006]. Single-walledcarbon nanotube (SWCNT)-induced interstitial fibrosisin the lungs of rats is associated with increasedlevels of PDGF mRNA <strong>and</strong> the formation of uniqueintercellular carbon structures that bridge alveolarmacrophages in situ. Part Fibre Toxicol 3(15).Maynard AD, Kuempel E [2005]. Airborne nanostructuredparticles <strong>and</strong> occupational health. JNanopart Res 7(6):587–614.Maynard AD, Baron PA, Foley M, Shvedova AA,Kisin ER, Castranova V [2004]. <strong>Exposure</strong> <strong>to</strong> carbonnanotube material: aerosol release during the h<strong>and</strong>lingof unrefined single walled carbon nanotubematerial. J Toxicol Environ Health A 67(1):87–107.McDow SR, Huntzicker JJ [1990]. Vapor adsorptionartifact in the sampling of organic aerosol: Facevelocity effects. Atmos Environ 24A:2563–2571.Mercer R, Scabilloni J, Wang L, Kisin E, Murray AD,Shvedova AA, Castranova AV [2008]. Alteration ofdeposition patterns <strong>and</strong> pulmonary response as aresult of improved dispersion of aspirated singlewalledcarbon nanotubes in a mouse model. Am JPhysiol Lung Cell Mol Physiol 294(1):L87–L97.Mercer RR, Scabilloni JF, Wang L, Battelli LA,Castranova V [2009]. Use of labeled single walledcarbon nanotubes <strong>to</strong> study translocation from thelungs. The Toxicologist 108:A2192.Mercer RR, Hubbs AF, Scabilloni JF, Wang L, BattelliLA, Schwegler-Berry D, Castranova V, PorterDW [2010]. Distribution <strong>and</strong> persistence of pleuralpenetrations by multi-walled carbon nanotubes.Particle Fibre Toxicol 7(28):1–11.Mercer RR, Hubbs AF, Scabilloni JF, Wang L, BattelliLA, Friend S, Castranova V, Porter DW [2011].Pulmonary fibrotic response <strong>to</strong> aspiration of multiwalledcarbon nanotubes. Part Fibre Toxicol 8(1):21.Methner MM, Birch ME, Evans DE, Ku B-K,Crouch KG, Hoover MD [2007]. Mazzuckelli LF,ed. Case study: identification <strong>and</strong> characterizationof potential sources of worker exposure <strong>to</strong> carbonnanofibers during polymer composite labora<strong>to</strong>ryoperations. J Occup Environ Hyg 4(12):D125–D130.80 NIOSH CIB 65 • <strong>Carbon</strong> <strong>Nanotubes</strong> <strong>and</strong> <strong>Nanofibers</strong>
Methner M, Hodson L, Geraci C [2010a]. Nanoparticleemission assessment technique (NEAT) for theidentification <strong>and</strong> measurement of potential inhalationexposure <strong>to</strong> engineered nanomaterials—part A.J Occup Environ Hyg 7(3):127–132 [http://dx.doi.org/10.1080/15459620903476355].Methner M, Hodson L, Dames A, Geraci C [2010b].Nanoparticle emission assessment technique (NEAT)for the identification <strong>and</strong> measurement of potentialinhalation exposure <strong>to</strong> engineered nanomaterials—part B: Results from 12 field studies. J Occup EnvironHyg 7(3):163–176.Milne WI, Mann M, Dijon J, Bachmann P, McLaughlinJ, Robertson J, Teo KBK, Lewalter A, de SouzaM, Boggild P, Briggs A, Mogensen KB, Gabriel J-CP,Roche S, Baptist R [2008]. <strong>Carbon</strong> nanotubes. E-NanoNewsletter 13:5–32 [http://www.phan<strong>to</strong>msnet.net/files/E_NANO_Newsletter_Issue13.pdf].Mitchell LA, Gao J, Wal RV, Gigliotti A, BurchielSW, McDonald JD [2007]. Pulmonary <strong>and</strong> systemicimmune response <strong>to</strong> inhaled multiwalled carbonnanotubes. Toxicol Sci 100(1):203−214.Mitchell LA, Lauer FT, Burchiel SW, McDonald JD[2009]. Mechanisms for how inhaled multiwalledcarbon nanotubes suppress systemic immunefunction in mice. Nat Nanotechnol 4(7):451–456.Monteiro-Riviere NA, Nemanich RJ, Inman AO,Wang YY, Riviere JE [2005]. Multi-walled carbonnanotubes interaction with human epidermal keratinocytes.Toxicol Lett 155(3):377–384.Morimo<strong>to</strong> Y, Hirohashi M, Kobayashi N, Ogami A,Horie M, Oyabu T, Myojo T, Hashiba M, MizuguchiY, Kambara T, Lee BW, Kuroda E, Shimada M, WangWN, Mizuno K, Yamamo<strong>to</strong> K, Fujita K, NakanishiJ, Tanaka I [2011]. Pulmonary <strong>to</strong>xicity of well-dispersedsingle-wall carbon nanotubes after inhalation.Nano<strong>to</strong>xicology. Sep 26. [Epub ahead of print].Morimo<strong>to</strong> Y, Hirohashi M, Ogami A, Oyabu T,Myojo T, Todoroki M, Yamamo<strong>to</strong> M, Hashiba M,Mizuguchi Y, Lee BW, Kuroda E, Shimada M, WangWN, Yamamo<strong>to</strong> K, Fujita K, Endoh S, Uchida K,Kobayashi N, Mizuno K, Inada M, Tao H, Nakaza<strong>to</strong>T, Nakanishi J, Tanaka I [2012]. Pulmonary <strong>to</strong>xicityof well-dispersed multi-wall carbon nanotubesfollowing inhalation <strong>and</strong> intratracheal instillation.Nano<strong>to</strong>xicology 6(6):587–599.Morrow PE [1988]. Possible mechanisms <strong>to</strong> explaindust overloading of the lungs. Fundam ApplToxicol 10(3):369–384.Muhle H, Creutzenberg O, Bellman B, Heinrich U,Ketkar M, Mermelstein R [1990]. Dust overloadingof lungs: investigations of various materials, speciesdifferences, <strong>and</strong> irreversibility of effects. J AerosolMed 3 (Suppl. 3):S111–S128.Muhle H, Bellmann B, Creutzenberg O, DasenbrockC, Ernst H, Kilpper R, MacKenzie JC, Morrow P,Mohr U, Takenaka S, Mermelstein R [1991]. Pulmonaryresponse <strong>to</strong> <strong>to</strong>ner upon chronic inhalationexposure in rats. Fund Appl Toxicol 17:280–299.Muller J, Huaux F, Moreau N, Misson P, HeilierJF, Delos M, Arras M, Fonseca A, Nagy JB,Lison D [2005]. Respira<strong>to</strong>ry <strong>to</strong>xicity of multiwallcarbon nanotubes. Toxicol Appl Pharmacol207(3):221–231.Muller J, Huaux F, Fonseca A, Nagy JB, Moreau N,Delos M [2008a]. Structural defects play a majorrole in the acute lung <strong>to</strong>xicity of multiwall carbonnanotubes: <strong>to</strong>xicological aspects. Chem Res Toxicol21(9):1698–1705.Muller J, Decordier I, Hoet PH, Lombaert N,Thomassen L, Huaux F, Lison D, Kirsch-VoldersM [2008b]. Clas<strong>to</strong>genic <strong>and</strong> aneugenic effects ofmulti-wall carbon nanotubes in epithelial cells.Carcinogenesis 29(2):427–433.Muller J, Delos M, Panin N, Rabolli V, Huaux F,Lison D [2009]. Absence of carcinogenic response<strong>to</strong> multiwall carbon nanotubes in 2-year bioassayin the peri<strong>to</strong>neal cavity of the rat. Toxicol Sci110(2):442–448.Murphy FA, Pol<strong>and</strong> CA, Duffin R, Al-Jamal KT,Ali-Boucetta H, Nunes A, Byrne F, Prina-MelloA, Volkov Y, Li S, Mather SJ, Bianco A, Pra<strong>to</strong> M,Macnee W, Wallace WA, Kostarelos K, DonaldsonNIOSH CIB 65 • <strong>Carbon</strong> <strong>Nanotubes</strong> <strong>and</strong> <strong>Nanofibers</strong>81
- Page 1 and 2:
CURRENT INTELLIGENCE BULLETIN 65Occ
- Page 3 and 4:
Current Intelligence Bulletin 65Occ
- Page 5 and 6:
ForewordThe Occupational Safety and
- Page 7 and 8:
Executive SummaryOverviewCarbon nan
- Page 9 and 10:
2009; Pauluhn 2010a; Porter et al.
- Page 11 and 12:
neurogenic sig nals from sensory ir
- Page 13 and 14:
possible. Until the results from an
- Page 15 and 16:
••Follow exposure and hazard as
- Page 17 and 18:
Periodic Evaluations••Evaluatio
- Page 19 and 20:
ContentsForeword ..................
- Page 21 and 22:
A.3.2 Comparison of Short-term and
- Page 23 and 24:
ESPFeFMPSFPSSgGMGSDHCLHECHEPAhrISOI
- Page 25 and 26:
AcknowledgementsThis Current Intell
- Page 27 and 28:
1 IntroductionMany nanomaterial-bas
- Page 29:
2 Potential for ExposureThe novel a
- Page 32 and 33:
CNMs, with MWCNT agglomerates obser
- Page 34 and 35:
composite materials with local exha
- Page 36 and 37:
information on air contaminants. Sa
- Page 39 and 40:
3 Evidence for Potential Adverse He
- Page 41 and 42:
decreasing agglomerate size increas
- Page 43 and 44:
examined up to 60 days post-exposur
- Page 45 and 46:
3.3 SWCNT and MWCNTIntraperitoneal
- Page 47 and 48:
The same potency sequence was obser
- Page 49 and 50:
Table 3-3. Findings from published
- Page 51 and 52:
Table 3-5. Findings from published
- Page 53 and 54:
Table 3-6. Findings from published
- Page 55 and 56: Table 3-7 (Continued). Findings fro
- Page 57: Table 3-8. Findings from published
- Page 60 and 61: length, respectively) [Muller et al
- Page 63 and 64: 5 CNT Risk Assessment and Recommend
- Page 65 and 66: A-6). Risk estimates derived from o
- Page 67 and 68: Table 5-4. Factors, assumptions, an
- Page 69 and 70: and analytical methods. NIOSH is re
- Page 71 and 72: Table 5-5. Recommended occupational
- Page 73 and 74: deficits in animals or clinically s
- Page 75: (3) Rat lung dose estimationIn the
- Page 78 and 79: tasks where worker exposures exceed
- Page 80 and 81: As part of the evaluation of worker
- Page 82 and 83: Table 6-1. EC LODs and LOQs for 25-
- Page 84 and 85: 6.2 Engineering ControlsOne of the
- Page 86 and 87: Table 6-6 (Continued). Examples of
- Page 88 and 89: Table 6-7 (Continued). Engineering
- Page 90 and 91: exposure estimates for SWCNT on ind
- Page 92 and 93: Table 6-8. Respiratory protection f
- Page 94 and 95: ••Workers in areas or in jobs w
- Page 97 and 98: 7 Research NeedsAdditional data and
- Page 99 and 100: ReferencesACGIH [1984]. Particle si
- Page 101 and 102: Bolton RE, Vincent HJ, Jones AD, Ad
- Page 103 and 104: eport issued on July 22, 2011. NEDO
- Page 105: Kobayashi N, Naya M, Mizuno K, Yama
- Page 109 and 110: Human Services, Centers for Disease
- Page 111 and 112: Piegorsch WW, Bailer AF [2005]. Qua
- Page 113 and 114: AD, Baron PA [2003]. Exposure to ca
- Page 115: Varga C, Szendi K [2010]. Carbon na
- Page 119 and 120: ContentsA.1 Introduction ..........
- Page 121 and 122: A.1 IntroductionThe increasing prod
- Page 123 and 124: provide an informal check on the es
- Page 125 and 126: these same dose groups; this effect
- Page 127 and 128: Table A-1. Rodent study information
- Page 129 and 130: the deposited (no clearance) and th
- Page 131 and 132: The other BMDS models failed to con
- Page 133 and 134: Figure A-2. Benchmark dose model (m
- Page 135 and 136: Figure A-3 (continued). Benchmark d
- Page 137 and 138: Table A-3. Benchmark dose estimates
- Page 139 and 140: Table A-5. Benchmark dose estimates
- Page 141 and 142: histopathology grade 2 or higher lu
- Page 143 and 144: Table A-8. Working lifetime percent
- Page 145 and 146: developing early-stage adverse lung
- Page 147 and 148: Figure A-4. Dose-response relations
- Page 149 and 150: cell surface area). However, the wo
- Page 151 and 152: purified or unpurified (with differ
- Page 153 and 154: Table A-9. Comparison of rat or hum
- Page 155 and 156: A.6.1.3 Pulmonary Ventilation RateT
- Page 157 and 158:
used as the effect levels in evalua
- Page 159 and 160:
the DF estimate, although a larger
- Page 161 and 162:
or overloading, of particle clearan
- Page 163 and 164:
Table A-13. Human-equivalent retain
- Page 165 and 166:
A.7.1 Particle CharacteristicsBoth
- Page 167 and 168:
and density. The following MMAD and
- Page 169:
Table A-15. CNT lung dose normalize
- Page 172 and 173:
B.1 Key Terms Related toMedical Sur
- Page 175 and 176:
APPENDIX CNIOSH Method 5040
- Page 177 and 178:
filter. In the method evaluation, d
- Page 179 and 180:
Most of the studies on sampling art
- Page 181 and 182:
e analyzed to determine the onset o
- Page 184:
Delivering on the Nation’s promis